Skip to main content
ImmuneCited

Pelargonium sidoides के लिए Acute Bronchitis

A

Meta-analyses demonstrate Pelargonium sidoides (EPs 7630) may significantly reduce bronchitis symptom severity and working inability. Approved as a medicine for respiratory infections in multiple countries. RCT showed working inability decreased to 16% vs 43% in placebo group after 7 days.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dpelargonium\u002Dsidoides\u0026condition\u003Dacute\u002Dbronchitis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

निष्कर्ष

Meta-analyses demonstrate Pelargonium sidoides (EPs 7630) may significantly reduce bronchitis symptom severity and working inability. Approved as a medicine for respiratory infections in multiple countries. RCT showed working inability decreased to 16% vs 43% in placebo group after 7 days.

Key Study Findings

Other
Research Landscape and Emerging Trends in Herbal Medicine for Pediatric Respiratory Tract Infections: A CiteSpace-Based …
Dose: None बनाम: None Outcome: research landscape of herbal medicine for pediatric RTIs प्रभाव: None None

जनसंख्या: pediatric patients with respiratory tract infections

Systematic Review
Pelargonium sidoides - from ethnopharmacology to evidence-based medicine: a systematic review.
Dose: None बनाम: None Outcome: clinical efficacy of Pelargonium sidoides for respiratory tract … प्रभाव: None None

जनसंख्या: patients with acute bronchitis, rhinosinusitis, and tonsillopharyngitis

Randomized Controlled Trial n=240 1 weeks Double-blind
Efficacy and Safety of YJP-40 in Patients with Acute Bronchitis: A Randomized, Double-Blind, Parallel Group …
Dose: None बनाम: Umckamin syrup (P. sidoides extract alone) Outcome: Change in bronchitis severity score (BSS) at day … प्रभाव: BSS change: -4.31 vs -4.36 non-inferiority demonstrated

जनसंख्या: Patients with acute bronchitis from 7 hospitals

Randomized Controlled Trial 1 weeks Double-blind
Efficacy and safety of mixture of ivy leaf extract and coptidis rhizome in the treatment …
Dose: Ivy leaf extract + Coptidis rhizome बनाम: Pelargonium sidoides extract Outcome: Bronchitis severity score (BSS) प्रभाव: None None

जनसंख्या: Adults with acute bronchitis

Review
Chronobiological Efficacy of Combined Therapy of Pelargonium Sidoides and Melatonin in Acute and Persistent Cases …
Dose: None बनाम: None Outcome: inflammation markers प्रभाव: None None

जनसंख्या: Covid-19

Randomized Controlled Trial n=591 1.0 weeks Open-label
Safety of Pelargonium extract EPs 7630 in young children with acute bronchitis.
Dose: 7.2% बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: Ab received eps 7630 syrup or solution for 7 days

Key Statistics

8

अध्ययन

2000

प्रतिभागी

Positive

A

ग्रेड

Referenced Papers

Frontiers in pediatrics 2023 7 उद्धरण
Multidisciplinary respiratory medicine 2023 4 उद्धरण
Complementary therapies in … 2020 36 उद्धरण
The Cochrane database … 2013 125 उद्धरण
Current medical research … 2013 25 उद्धरण
Phytomedicine : international … 2008 100 उद्धरण
The Cochrane database … 2008 71 उद्धरण
Phytomedicine : international … 2007 39 उद्धरण
Wiener medizinische Wochenschrift … 2007 23 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
30 drops (1.5 mL) liquid extract 3x/day or 20 mg EPs 7630 tablets 3x/day
duration:
7-14 days

अधिकतम सीमा: No established UL

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
None -- Positive --
None -- Positive --
None 1 weeks Neutral 240
Ivy leaf extract + Coptidis rhizome 1 weeks Positive --
None -- Mixed --
7.2% 1.0 weeks Positive 591
83.6% 10.4 weeks Mixed 505
None -- Positive 2195

सेवन का सर्वोत्तम समय: At onset of respiratory symptoms; 3x daily for up to 14 days

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Gastrointestinal discomfort (rare)
  • Allergic skin reactions (rare)
  • Nosebleeds (rare)
  • Hepatotoxicity (very rare, case reports)

ज्ञात अंतःक्रियाएँ

  • Anticoagulants (theoretical increased bleeding risk due to coumarin content)
  • Immunosuppressant medications (may modulate immune function)

सहनीय अधिकतम सेवन: No established UL

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Pelargonium sidoides help with Acute Bronchitis?
Based on 8 studies with 2,000 participants, there is strong evidence from multiple clinical trials that Pelargonium sidoides may support Acute Bronchitis management. Our evidence grade is A (Strong Evidence).
How much Pelargonium sidoides should I take for Acute Bronchitis?
Studies have used various dosages. A commonly studied range is 30 drops (1.5 mL) liquid extract 3x/day or 20 mg EPs 7630 tablets 3x/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Pelargonium sidoides?
Reported side effects may include Gastrointestinal discomfort (rare), Allergic skin reactions (rare), Nosebleeds (rare), Hepatotoxicity (very rare, case reports). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Pelargonium sidoides and Acute Bronchitis?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 8 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री Acute Bronchitis

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।